FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 313:715-720 September 19, 1985 Number 12 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

It has been suggested that there are altered levels of norepinephrine or other neurotransmitters at functionally important receptors in patients with depressive disorders. This hypothesis is difficult to study in the human central nervous system. However, noradrenergic function can be assessed indirectly with peripheral-blood lymphocytes used as a model of the beta-adrenergic receptor complex. We found that drug-free inpatients with endogenous depression had lower isoproterenol-stimulated cyclic AMP levels in intact lymphocytes than did healthy control subjects (3.9 +/- 0.5 vs. 7.4 +/- 1.0 pmol per 10(6) cells, P less than 0.01). The density and affinity of beta-adrenergic receptors were similar in controls and depressed subjects (beta-receptor number, 5.4 +/- 0.7 and 5.3 +/- 0.8 fmol per 10(6) cells; binding affinity, 106 +/- 7.6 vs. 99.2 +/- 11.4 pM, respectively). When the depressed patients were subdivided by psychomotor manifestations, binding characteristics were indistinguishable among the subgroups. However, a significant reduction in beta-adrenergic responsiveness was observed in patients with psychomotor agitation, as compared with controls (2.6 +/- 0.5 vs. 7.4 +/- 1.0 pmol per 10(6) cells, P less than 0.01), but not in patients with psychomotor retardation (5.8 +/- 1.1 pmol per 10(6) cells, P less than 0.05). Thus, the desensitization of beta-adrenergic receptors was correlated more closely with the severity of psychomotor agitation than with the overall severity of depression.

This article has been cited by other articles:

• Chen, G., Hasanat, K. A., Bebchuk, J. M., Moore, G. J., Glitz, D., Manji, H. K. (1999). Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and Antidepressants. Psychosom. Med. 61: 599-617 [Abstract] [Full Text]  
• Wright, R. J, Rodriguez, M., Cohen, S. (1998). Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax 53: 1066-1074 [Full Text]  
• Avissar, S., Nechamkin, Y., Roitman, G., Schreiber, G. (1998). Dynamics of ECT Normalization of Low G Protein Function and Immunoreactivity in Mononuclear Leukocytes of Patients With Major Depression. Am. J. Psychiatry 155: 666-671 [Abstract] [Full Text]  
• Weiler, P. G., Mungas, D., Bernick, C. (1988). Propranolol for the Control of Disruptive Behavior in Senile Dementia. J Geriatr Psychiatry Neurol 1: 226-230